ArticleJournal of bone and mineral metabolism2021

Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients.

Tomohiro Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.